Skip to main content

Day: December 15, 2020

Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) — Havn Life Sciences Inc. (CSE : HAVN) (FSE : 5NP) (the “Company” or “Havn Life”) is pleased to announce that it has entered into an amended agreement with Eight Capital, pursuant to which Eight Capital has now agreed to buy, on a bought deal basis, 9,346,000 units (“Units”) at a price of $1.07 per Unit (the “Issue Price”), for gross proceeds of approximately $10,000,200 (the “Offering”). Each Unit will consist of one common share in the capital of the Company (a “Share”) and one warrant (a “Warrant”), with each Warrant entitling the holder thereof to purchase one additional Share at an exercise price of $1.34 for a period of 36 months from the date of issuance. The Offering is expected to...

Continue reading

Sofragi : AGM du 18.12.20 à huis clos – Modalités de tenue de l’Assemblée Générale

COMMUNIQUÉ DE PRESSEParis, le 15 décembre 2020Modalités de tenue de l’Assemblée Générale Mixte du 18 décembre 2020 à huis closDans le cadre de la situation sanitaire actuelle, liée au SARS-CoV-2, le Conseil d’administration a décidé de tenir l’assemblée générale mixte du 18 décembre 2020 à huis-clos, sans la présence physique des actionnaires et des personnes ayant le droit d’y assister, conformément aux dispositions de l’article 4 de l’ordonnance modifiée n° 2020-321 du 25 mars 2020.Il ne sera donc pas délivré de cartes d’admission, mais cette assemblée sera intégralement retransmise sur le site dédié https://channel.royalcast.com/webcast/sofragi/20201218_1, en direct dès 10h00. Elle sera également consultable en différé, et cela pendant 5 ans, à cette même adresse.Il est précisé que cette retransmission en direct de l’assemblée ne permettra...

Continue reading

One80 Intermediaries Enters Warranty Business With Acquisition of Safeware

BOSTON, Dec. 15, 2020 (GLOBE NEWSWIRE) — One80 Intermediaries (One80), a national wholesale broker, program manager, third-party administrator (TPA), and insurance aggregator headquartered in Boston, today announced that it has acquired Safeware, a fully licensed insurance agency and TPA for extended warranty and service plan solutions. Marsh, Berry & Company, Inc. served as the exclusive advisor to Safeware; terms of the deal were not disclosed.Founded in 1982, Safeware is based in Dublin, Ohio and provides original equipment manufacturer warranties, limited warranties, extended service plans, extension plans, and insurance policies. Safeware has a diverse customer base including small and medium-sized enterprises, large resellers, and many of the country’s most recognized universities and colleges.“I am confident that Safeware...

Continue reading

Extraordinary General Meeting in IDEX Biometrics Held on 15 December 2020

IDEX Biometrics ASA held an extraordinary general meeting on 15 December 2020. 332.6 million shares or 40% of the capital was represented at the meeting.Agenda item 3 was withdrawn. All other resolutions were made as proposed in the notice of the meeting.For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186Derek P. D’Antilio, Chief Financial OfficerE-mail: derek.dantilio@idexbiometrics.comTel: +1 978 273 1344About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal touch-free authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings. We invent, engineer, and commercialize...

Continue reading

Cameco suspend temporairement la production de la mine de Cigar Lakee Mine

SASKATOON, Saskatchewan, 15 déc. 2020 (GLOBE NEWSWIRE) — Cameco (TSX: CCO; NYSE: CCJ) a annoncé aujourd’hui devoir suspendre temporairement la production de sa mine d’uranium de Cigar Lake, dans le nord de la Saskatchewan, au cours des prochaines semaines, en raison des risques croissants liés à la pandémie de coronavirus (COVID-19).La Saskatchewan subit une progression importante de la pandémie, ce qui accroît l’incertitude quant au maintien de l’exploitation de Cigar Lake, en partie en raison de difficultés d’accès à du personnel d’exploitation qualifié. Nous allons continuer à suivre attentivement la situation de la COVID-19 en Saskatchewan, en particulier dans le nord de la province, ainsi que les répercussions sur nos communautés et la disponibilité des employés et des entrepreneurs à se rendre...

Continue reading

Novo Identifies Numerous Oxide Targets for Follow Up in 2021 at Its Newly Consolidated Nullagine Gold Project

VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce it has identified a series of highly prospective oxide gold targets within its newly consolidated tenure comprising its 100% controlled Nullagine Gold Project (“NGP”) which includes the recently acquired Golden Eagle processing facility (“Golden Eagle Mill”). These gold targets add to the significant exploration potential the Company has recently discussed at Beatons Creek (please refer to the Company’s news releases dated October 6, 2020 and November 5, 2020 for further details).With the Company’s recent acquisition of Millennium Minerals Limited (“Millennium”) and additional tenure from the Creasy Group, Novo now controls over 1,250 km sq of broadly contiguous tenements...

Continue reading

Global Financial Services Group Expands Partnership with Bridgeline And Renews Software License for OrchestraCMS

WOBURN, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider in cloud-based digital experience software, announced today that a leading global financial services group renewed their OrchestraCMS license for over $850k through 2021. The company will leverage Bridgeline’s services to power their online experiences, including an internal communication portal for the entire enterprise.With headquarters in the US and Canada and offices across Europe and Asia, one of the company’s primary goals is unifying its global audience through leading-edge digital experiences and being the top customer-centric global financial services company in the industry. To accomplish this the company uses Salesforce, a long-time partner of Bridgeline, and OrchestraCMS. The company leverages their Salesforce...

Continue reading

The 4Less Group, Inc. (OTC: FLES) Reports 23.5% Increase in 3rd Quarter Sales

LAS VEGAS, Dec. 15, 2020 (GLOBE NEWSWIRE) — The 4Less Group, Inc. (OTC: FLES), the premiere online marketplace for automotive specialty equipment parts and accessories in the U.S., today reported total revenues of $2.33 million for its third quarter ended October 31, 2020, an increase of 23.50% from the previous year’s third quarter.“Our results reflect an improving business environment and demonstrates our laser focus and discipline on managing costs, which is enabling us to deliver our best year ever,” said Timothy Armes, CEO of The 4Less Group, Inc. “We were also able to accomplish our goal of restructuring our debt including removing approximately all of our $2.2 million of convertible debt, including both principal and accrued interest, in exchange for a promissory note of $1.2 million bearing interest at...

Continue reading

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical needConcurrent PIPE financing to be used to fund clinical trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare-focused investors OrbiMed and Peter ThielCAMBRIDGE, Mass. and TEL-AVIV, Israel, Dec. 15, 2020 (GLOBE NEWSWIRE) — Anchiano Therapeutics Ltd. (“Anchiano”) (Nasdaq: ANCN), a preclinical biopharmaceutical company, and Chemomab Ltd. (“Chemomab”), a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, announce their entry into a definitive merger agreement pursuant to which the shareholders of Chemomab would become...

Continue reading

Polydex Pharmaceuticals Issues Third Quarter Financial Results

TORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) — Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the third quarter of fiscal 2021, the period ending October 31, 2020. All figures are reported in U.S. dollars.The company fundamentals remain strong with a good cash position and balance sheet even in light of the COVID-19 pandemic.The demand for Native Dextran was consistent throughout the third quarter, has fluctuated in Q4 thus far, but appears to have stabilized going forward. The COVID pandemic continues to cause uncertainty with some customers, who are cautious about forecasting their needs with any clarity.George Usher, President and CEO stated “We are pleased that we have been able to remain profitable this year, despite the worldwide impact of the Covid-19 pandemic.” He...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.